Determination of fifteen bioactive components in Radix et Rhizoma Salviae Miltiorrhizae by high-performance liquid chromatography with ultraviolet and mass spectrometric detection

被引:67
作者
Cao, Jun [1 ]
Wei, Ying-Jie [1 ]
Qi, Lian-Wen [1 ]
Li, Ping [1 ]
Qian, Zheng-Ming [1 ]
Luo, Hou-Wei [1 ]
Chen, Jun [1 ]
Zhao, Jing [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmacognosy, Key Lab Modern Chinese Med, Minist Educ, Nanjing 210009, Peoples R China
基金
俄罗斯基础研究基金会;
关键词
Radix et Rhizoma Salviae Miltiorrhizae; phenolic acids; diterpenoids; HPLC-UV; LC-ESI-TOF/MS; quality control;
D O I
10.1002/bmc.911
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A high-performance liquid chromatographic (HPLC) method coupled with ultraviolet (UV) and electrospray ionization time-of-flight mass spectrometry (ESI-TOF/MS) was established for simultaneous qualitative and quantitative determination of nine phenolic acids and six diterpenoids in Radix et Rhizoma Salviae Miltiorrhizae (RRSM). The optimal chromatographic conditions were achieved on a Zorbax C-18 column by gradient elution with 0.1% (v/v) aqueous formic acid and acetonitrile as mobile phase at the flow rate of 1.0 mL/min. The detection wavelength at 281 nm was chosen to determine the 15 bioactive components, namely danshensu (1), protocatechuic acid (2), protocatechuic aldehyde (3), caffeic acid (4), rosmarinic acid (5), lithospermic acid (6), salvianolic acid B (7), salvianolic acid A (8), salvianolic acid C (9); dihydrotanshinone I (10), cryptotanshinone (11), tanshinone I (12), methylene tanshiqunone (13), tanshinone IIA (14) and miltirone (15). Additionally, LC-ESI-TOF/MS was used to make definite identification of the constituents in samples in comparison with those reference compounds. The validation of the method included tests of linearity, sensitivity, repeatability, stability and recovery. The proposed method was successfully applied to quantify the 15 components in 21 samples; significant variations were demonstrated in the contents of the samples from diverse species and origins. The developed method could be used to effectively and comprehensively evaluate the quality of RRSM for its clinical safety and efficacy. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 31 条
[1]
Bai RJ, 2006, J HUBEI COLL TCM HUB, V8, P11
[2]
Application of non-aqueous micellar electrokinetic chromatography to the analysis of active components in radix Salviae miltiorrhizae and its medicinal preparations [J].
Chen, AJ ;
Li, CH ;
Gao, WH ;
Hu, ZD ;
Chen, XG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (04) :811-816
[3]
Production of rosmarinic acid and lithospermic acid B in Ti transformed Salvia miltiorrhiza cell suspension cultures [J].
Chen, H ;
Chen, F ;
Zhang, YL ;
Song, JY .
PROCESS BIOCHEMISTRY, 1999, 34 (08) :777-784
[4]
Separation and identification of water-soluble salvianolic acids from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography and ESI-MS analysis [J].
Chen, JH ;
Wang, FM ;
Lee, FSC ;
Wang, XR ;
Xie, MY .
TALANTA, 2006, 69 (01) :172-179
[5]
*CHIN PHARM COMM, 2005, CHIN PHARM 1, P52
[6]
Cytotoxic and aromatic constituents from Salvia miltiorrhiza [J].
Don, MJ ;
Shen, CC ;
Syu, WJ ;
Ding, YH ;
Sun, CM .
PHYTOCHEMISTRY, 2006, 67 (05) :497-503
[7]
One-step separation and purification of 3,4-dihydroxyphenyllactic acid, salvianolic acid B and protocatechualdehyde from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography [J].
Gu, Ming ;
Wang, Xiaolei ;
Su, Zhiguo ;
Fan Ouyang .
JOURNAL OF CHROMATOGRAPHY A, 2007, 1140 (1-2) :107-111
[8]
Tanshinone IIA inhibits LPS-induced NF-κB activation in RAW 264.7 cells:: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways [J].
Jang, Seon ;
Kim, Hyung Jin ;
Kim, Young-Jun ;
Jeong, Seung-Il ;
You, Yong-Ouk .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 542 (1-3) :1-7
[9]
Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats [J].
Ji, XY ;
Tan, BKH ;
Zhu, YC ;
Linz, W ;
Zhu, YZ .
LIFE SCIENCES, 2003, 73 (11) :1413-1426
[10]
JIAN YH, 1989, J CHINA PHARM U, V20, P5